Overview
Cabotegravir plus Rilpivirine for Persons with HIV and Adherence Challenges
Written by: Aadia I. Rana, M.D.Lu Zheng, Ph.D.Jose Castillo-Mancilla, M.D.Yajing Bao, M.S.Sara Sieczkarski, Ph.D.Kristina M. Brooks, Pharm.D.Jordan E. Lake, M.D.Carl Fichtenbaum, M.D.Sonya L. Heath, M.D.Pablo F. Belaunzaran-Zamudio, M.D.Karin Klingman, M.D.Lawrence Fox, M.D.Tia Morton, R.N., M.S.Michael Stirratt, Ph.D.Jonathan Z. Li, M.D., M.M.Sc.Edward P. Acosta, Pharm.D.Charles Venuto, Pharm.D.Omar Galárraga, Ph.D.Steven Shoptaw, Ph.D.David Wohl, Ph.D.Madison Green, B.S.Ceora Beijer, B.S.Kathie Ferbas, Ph.D.Cheryl Jennings, B.S.Katherine Shin, Pharm.D.Romina Collahua, M.Sc.Michael Dorosh, M.A.Paul Wannamaker, B.A.Ronald D’Amico, M.D.Kimberly Smith, M.D., M.P.H.William Spreen, Pharm.D.Kati Vandermeulen, M.Sc.Rodica Van Solingen-Ristea, M.D.Chanelle Wimbish, B.S.Karen T. Tashima, M.D.Raphael J. Landovitz, M.D.
Find these authors on Roon
